The federal right-to-try law's effect on the FDA, the gamification of science, how the Conscience and Religious Freedom Division is changing health care, and more in the latest issue.
Following a decline in notification rates in 2016, the number of gonorrhoea cases has gone up by 17% across the reporting EU/EEA countries with more than 89,000 confirmed diagnoses in 2017 -- equivalent to 240 cases a day.
Published in Nature Medicine, results of WINTHER, the first study pioneered by the WIN Consortium -- Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial -- shows that RNA profiling together with DNA testing matches more patients with advanced cancer to personalized therapies than DNA profiling for tumor mutations alone.
Restrictive prior authorization practices cause unnecessary delays and interference in care decisions for cancer patients, according to a new survey of nearly 700 radiation oncologists -- physicians who treat cancer patients using radiation-- released by the American Society for Radiation Oncology (ASTRO). Experts will discuss the findings at an online press briefing at 9:30 am ET on Thursday, April 25; register at bit.ly/ASTROPriorAuthBriefing.
For many parents, talking to their children about substance use is like navigating a field of landmines. It's difficult to know exactly what to say and how to say it. But a new study from the University of British Columbia is showing the way forward. Researchers found that a harm reduction message resonated the most with teens, instead of the typical "don't do drugs" talk.
One in six countries is expected to have substantially high out-of-pocket spending as a proportion of total health expenditures by 2050, according to a new scientific study. As low-income countries increase their GDP, they often face the 'missing middle' problem: As they receive less development assistance, they are not able to fill the resulting gap due to slower growth in government health spending. As a result, many low- and middle-income countries rely more heavily on out-of-pocket spending.
Scientists from EMBL Heidelberg have discovered that the collection of proteins in an animal cell -- called the proteome -- is substantially affected by both the animal's sex and its diet. Understanding these individual proteomes might provide a basis for personalised treatments for humans in the future.
A new investigation finds that while insurance coverage for depression has increased, treatment rates are lower than expected, indicating that non-financial barriers to patient care still remain.
A paper by Columbia Mailman School's John Rowe, M.D., Julius Richmond Professor of Health Policy and Aging, in the journal Health Affairs outlines the challenges we face as the US becomes an 'aging society.' This transformation has major implications for our core institutions which were not designed to support this changing population distribution.
Scientists used a compound found in a shrub native to Africa to reveal the three major shapes of the serotonin transporter, a protein in the brain linked to anxiety and depression. The discovery opens new avenues for developing medications to treat addiction.